Joint Formulary & PAD

Tranexamic acid - Mucositis - chemotherapy / radiotherapy induced

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Mouthwash
  • Soluble tablets
Associated Icons :
SPC
Restrictions / Comments :
Important
5% mouthwash - unlicensed product. Used in line with St Luke's SACT protocols
 

Status 2

Red
Formulations :
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important
SASH - Tablets used to make a mouthwash (off-label use). Use in line with St Luke's SACT protocols

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tranexamic acid
Indication :
Mucositis - chemotherapy / radiotherapy induced
Group Name :
Keywords :
Oropharyngeal lesions, oral ulceration, oral inflammation
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Tranexamic acid is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Mucositis - chemotherapy / radiotherapy induced.